Home Ricerca Sedi Chi siamo Organigramma Personale Contatti Didattica Login Documenti EN
Progetti in evidenza
INCIPIT
(Link esterno)

ISTAPCA
(1209 visite)

Fondo Europeo Pesca
(622 visite)

Euro-BioImaging
(Link esterno)

Fondazione Veronesi
(Link esterno)

LightDyNAmics
(1094 visite)

 INMiND
(1186 visite)

Instruct-IT
(Link esterno)

 PRIN
(1329 visite)

 eHealthNet
(1090 visite)

Ponrec
(1028 visite)

MFAG Grant
(1134 visite)

MERIT
(Link esterno)


Collegamenti

Ricerca:      Estesa  
    
Foto
NomeAntonella Zannetti
AreaRicerca e Sviluppo
QualificaRicercatore
SedeNapoli-De Amicis
IndirizzoVia De Amicis 95, 80145 Napoli - Italia
E-mailantonella.zannettiibb.cnr.it
Telefono ufficio+39 081 2203431
Cellulare+39 366.611.53.19
    Malattie Neoplastiche
    Gadd45 beta and its implication in chronic inflammation
    Characterization of neurotoxic and neuroprotective factors by using computational methodologies
    Monoclonal Antibodies for therapeutic and diagnostic applications
    Targeted Drug Delivery by integrin avb3 antagonist
    Protein aggregation and cytotoxicity: molecular, in vitro and in vivo biological studies
    Metals role in angiogenesis
    Drug Delivery
    Bioactive peptide-membrane assemblies
    Metals and small molecules in the regulation of the Ubiquitin Proteasome Pathway
    Protein semi-synthesis for biophysical and chemical biology applications
    Peptide modulators of the VEGF-dependent angiogenesis
    Peptides promoting reverse cholesterol transport
    CA IX as target for the development of new anti-tumour drugs
    Carbonic Anhydrase family as target for rational drug design
    Clinical Oncology
    Translational Molecular Imaging in Cancer
    Molecular imaging for personalized therapy in oncology
    Modeling radiation induced normal tissue effects
    Synthesis of small molecules, modified peptides and nucleobase-decorated peptides. Nucleic acid and protein binding studies
    Segmentazione cerebrale per applicazioni in radiologia oncologica
    Targeted Drug Delivery by integrin avb3 antagonist

Antonella Zannetti was graduated in Biological Sciences at the University of Rome “Tor Vergata” cum laude in 1991 and received her PhD in Molecular and Cellular Biology from the same University in 1995. From 1997 to 2001 she worked as research fellow in Molecular Oncology at the National Tumor Institute “Pascale” of Naples; at the “Federico II” University of Naples and at the Nuclear Medicine Study Center –CNR of Naples. Since 2001, she is Researcher at the Institute of Biostructures and Bioimages (IBB) of the Italian National Research Council. Since 2012, she is Responsible of Biological Laboratory of IBB (via T. De Amicis-Naples) and she is contract Professor in “Molecular Imaging “ of degree course in Medical Biotechnology, Department of Molecular Medicine and Medical Biotechnology at University “Federico II” of Naples. The research activities of Dr Zannetti are mainly focused on the development and preclinical validation in vitro and in vivo of innovative approaches for tumor diagnosis and therapy using molecular targets and labeled probe. Dr. Zannetti is author of publications reported in JCR Journals (including Cancer Research and Clinical Cancer Research). She also co-authored articles published in Books and Conference Proceedings. 


Contiene: [X]      Estesa     Autori: [X]  Tipo di lavoro: [X]   Data iniziale: Data finale: [X]      Sede: Affiliazione IBB     
    
[Pulisci modulo]

Bibliografia

Ordina per:   data    titolo    rivista    autori    impact factor

* Therapeutic Potential of a Novel alphavbeta(3) Antagonist to Hamper the Aggressiveness of Mesenchymal Triple Negative Breast Cancer Sub-Type (3 visite) (PDF 2 visite)
Hill BS, Sarnella A, Capasso D, Comegna D, Del Gatto A, Gramanzini M, Albanese S, Saviano M, Zaccaro L, Zannetti A
N/D (ISSN: 2072-6694linking), 2019 Jan 24; 11(2): N/D-N/D.
Impact Factor: 5.326
Dettagli    Esporta in BibTeX    Esporta in EndNote

* TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities (35 visite) (PDF 10 visite)
Camorani S, Fedele M, Zannetti A, Cerchia L
Pharmaceuticals (ISSN: 1424-8247print, 1424-8247linking), 2018 Nov 13; 11(4): N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer (133 visite) (PDF 22 visite)
Camorani S, Hill B, Collina F, Gargiulo S, Napolitano M, Cantile M, Di Bonito M, Botti G, Fedele M, Zannetti A, Cerchia L
Theranostics (ISSN: 1838-7640, 1838-7640electronic, 1838-7640linking), 2018 Oct 6; 8(18): 5178-5199.
Impact Factor: 8.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation (143 visite)
Greco A, Zannetti A, Pappata S, Albanese S, Coda AR, Ragucci M, Nardelli A, Brunetti A, Cuocolo A, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785linking, 1824-4785print, 1827-1936electronic), 2018 Mar; 62(1): 112-117.
Impact Factor: 2.413
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Autocrine signals increase Ovine Mesenchymal Stem Cells migration through Aquaporin-1 and CXCR4 overexpression (49 visite)
Pelagalli A, Nardelli A, Lucarelli E, Zannetti A, Brunetti A
J Cell Physiol (ISSN: 1097-4652electronic, 0021-9541linking), 2018 Jan 18; 233(8): 6241-6249.
Impact Factor: 4.08
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Chemical Modification for Proteolytic Stabilization of the Selective alphavbeta3 Integrin RGDechi Peptide: in Vitro and in Vivo Activities on Malignant Melanoma Cells (332 visite) (PDF 81 visite)
Comegna D, Zannetti A, Del Gatto A, De Paola I, Russo L, Di Gaetano S, Liguoro A, Capasso D, Saviano M, Zaccaro L
J Med Chem (ISSN: 1520-4804electronic, 0022-2623linking, 0022-2623print), 2017 Dec 14; 60(23): 9874-9884.
Impact Factor: 5.207
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of Bone Marrow-Derived Mesenchymal Stem Cells Homing Towards Triple-Negative Breast Cancer Microenvironment Using an Anti-PDGFRbeta Aptamer (324 visite) (PDF 104 visite)
Camorani S, Hill BS, Fontanella R, Greco A, Gramanzini M, Auletta L, Gargiulo S, Albanese S, Lucarelli E, Cerchia L, Zannetti A
Theranostics (ISSN: 1838-7640electronic, 1838-7640linking), 2017 Aug 22; 7(14): 3595-3607.
Impact Factor: 8.766
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype (74 visite)
Hill BS, Pelagalli A, Passaro N, Zannetti A
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2017 Aug 14; 8(42): 73296-73311.
Impact Factor: 5.168
Dettagli    Esporta in BibTeX    Esporta in EndNote

* A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors (70 visite) (PDF 88 visite)
Santagata S, Portella L, Napolitano M, Greco A, D'Alterio C, Barone MV, Luciano A, Gramanzini M, Auletta L, Arra C, Zannetti A, Scala S
Sci Rep (ISSN: 2045-2322electronic, 2045-2322linking), 2017 May 31; 7(1): 2554-2554.
Impact Factor: 4.259
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Aptamer-mediated impairment of EGFR-integrin alphavbeta3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers (71 visite) (PDF 105 visite)
Camorani S, Crescenzi E, Gramanzini M, Fedele M, Zannetti A, Cerchia L
Sci Rep (ISSN: 2045-2322electronic, 2045-2322linking), 2017 Apr 20; 7: 46659-46659.
Impact Factor: 4.259
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells (150 visite) (PDF 210 visite)
Pelagalli A, Nardelli A, Fontanella R, Zannetti A
Int J Mol Sc (ISSN: 1422-0067electronic, 1422-0067linking, 1661-6596), 2016 Jul 11; 17(7): N/D-N/D.
Impact Factor: 3.226
Dettagli    Esporta in BibTeX    Esporta in EndNote

* High-frequency ultrasound-guided injection for the generation of a novel orthotopic mouse model of human thyroid carcinoma (123 visite)
Greco A, Albanese S, Auletta L, Mirabelli P, Zannetti A, D'Alterio C, Di Maro G, Orlandella FM, Salvatore G, Soricelli A, Salvatore M
Thyroid (ISSN: 1557-9077electronic, 1050-7256linking), 2016 Feb 4; 26(4): 552-558.
Impact Factor: 5.515
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT (463 visite) (PDF 179 visite)
Gargiulo S, Anzilotti S, Coda AR, Gramanzini M, Greco A, Panico M, Vinciguerra A, Zannetti A, Vicidomini C, Dolle F, Pignataro G, Quarantelli M, Annunziato L, Brunetti A, Salvatore M, Pappata S
Eur J Nucl Med (ISSN: 1619-7089electronic, 1619-7070linking, 1619-7070print), 2016 Jan 27; 43(7): 1348-1359.
Impact Factor: 7.277
Dettagli    Esporta in BibTeX    Esporta in EndNote

* A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion (576 visite) (PDF 171 visite)
Fontanella R, Pelagalli A, Nardelli A, D'Alterio C, Ierano C, Cerchia L, Lucarelli E, Scala S, Zannetti A
Cancer Lett (ISSN: 1872-7980electronic, 0304-3835linking), 2015 Oct 27; 370(1): 100-107.
Impact Factor: 5.992
Dettagli    Esporta in BibTeX    Esporta in EndNote

* In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET (210 visite) (PDF 150 visite)
Vicidomini C, Panico M, Greco A, Gargiulo S, Coda ARD, Zannetti A, Gramanzini M, Roviello GN, Quarantelli M, Alfano B, Tavitian B, Dolle F, Salvatore M, Brunetti A, Pappata S
Nucl Med Biol (ISSN: 0969-8051, 1872-9614, 0883-2897), 2015 Mar; 42(3): 309-316.
Impact Factor: 2.429
Dettagli    Esporta in BibTeX    Esporta in EndNote

* High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma (94 visite)
Albanese S, Auletta L, Zannetti A, Di Maro G, Mirabelli P, D'Alterio C, Salvatore G, Soricelli A, Salvatore M, Greco A
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015; 42: S416-S416.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model (124 visite)
Greco A, D'Alterio C, Auletta L, Albanese S, Napolitano M, Portella L, Santagata S, Ierano C, Brunetti A, Scala S, Zannetti A
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2015; 42: S425-S425.
Impact Factor: 5.537
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Effects of Thyroid Blockade on Brain Imaging of Dopamine Transporter in Normal Mice (99 visite)
Greco A, Zannetti A, Coda ARD, Albanese S, Nardelli A, Roca A, Pappata S, Brunetti A, Cuocolo A
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2013 Oct; 40: N/D-N/D.
Impact Factor: 5.217
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (145 visite)
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Combined Imaging with 18F-FLT PET/CT and 99m-Tc-Hynic-Annexin V SPECT for Personalized Therapy with EGFR Antagonists and Bcl-xL Inhibitors in Non-Small Cell Lung Cancer (102 visite)
Zannetti A, Iommelli F, De Rosa V, Nardelli A, Ortosecco G, Del Vecchio S
European Journal Of Cancer (ISSN: 0959-8049), 2012 Nov; 48: N/D-N/D.
Impact Factor: 5.061
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Small animal SPECT with 99m-Tc-Hynic-annexin V for detection of non-small cell lung cancer resistance to EGFR antagonists and its reversal by Bcl-xL inhibitors (109 visite)
Zannetti A, Iommelli F, De Rosa V, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2012 Oct; 39: N/D-N/D.
Impact Factor: 5.114
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 3'-deoxy-3'-18F-fluorothymidine (FLT) PET/CT to guide therapy with epidermal growth factor receptor (EGFR) antagonists and Bcl-xL inhibitors in non-small cell lung cancer (237 visite)
Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 3'-deoxy-3'-18F-fluorothymidine PET/CT to guide therapy with epidermal growth factor receptor antagonists and Bcl-xL inhibitors in non-small cell lung cancer (175 visite)
Zannetti A, Iommelli F, Speranza A, Salvatore M, Del Vecchio S
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2012 Mar 1; 53(3): 443-450.
Impact Factor: 5.774
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Stato Dell’arte Dell’imaging Preclinico In Oncologia (100 visite)
Del Vecchio S, Zannetti A, Iommelli F, Fonti R, Speranza A
Q J Nucl Med Mol Imaging (ISSN: 1827-1936, 1827-1936electronic, 1824-4785linking), 2011; 55: 20-21.
Impact Factor: 2.256
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Automatic radiosynthesis of [F-18]-FBCHO-maleimide linker for Affibody labelling (110 visite)
Castaldi E, Ortosecco G, Nardelli A, Speranza A, Del Vecchio S, Zannetti A, Storto G, Pace L, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2010 Oct; 37: N/D-N/D.
Impact Factor: 5.036
Dettagli    Esporta in BibTeX    Esporta in EndNote

* PET/CT in cancer research: From preclinical to clinical applications (172 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Pizzuti LM, Lettieri A, Salvatore M
Contrast Media Mol Imaging (ISSN: 1555-4309, 1555-4309linking), 2010 Jul; 5(4): 190-200.
Impact Factor: 4.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of tumor microenvironment (113 visite)
Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 243-258.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of tumor microenvironment: Challenges and perspectives (175 visite)
Del Vecchio S, Zannetti A, Iommelli F, Lettieri A, Brunetti A, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2010 Jun; 54(3): 249-258.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5) (113 visite)
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A,  De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (147 visite)
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of Bcl-2/Bcl-x(L) dysregulated apoptotic program in NSCLC cells resistant to EGFR tyrosine kinase inhibitors (97 visite)
Zannetti A, Iommelli F, Fonti R, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* MicroPET/CT of mice bearing alpha(v)beta(3)-expressing tumors by a 18F-labeled bifunctional chimeric RGD peptide (118 visite)
Zannetti A, Iommelli F, Panico M, Del Gatto A, Zaccaro L, Saviano M, Pedone C, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* New high yield HPLC purification with ethanol of 18F-RGDEchi and directly injection in mice (119 visite)
Panico MM, Lang L, Greco A, Greco A, Gargiulo S, Larobina M, Del Vecchio S, Zannetti A, Zaccaro L, Zaccaro L, Del Gatto A, Saviano M, Alfano B, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Molecular imaging of drug resistance in cancer (114 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Lettieri A, Salvatore M
Minerva Biotecnol (ISSN: 1120-4826), 2009 Mar; 21(1): 31-36.
Impact Factor: 0.268
Dettagli    Esporta in BibTeX    Esporta in EndNote

* A new and selective radiolabeled alpha(V)beta(3) peptide antagonist as tracer in tumor diagnosis (101 visite)
De Luca S, Del Gatto A, Ruvo M, Panico M, Zannetti A, Del Vecchio S, Salvatore M, Pedone C, Saviano M, Zaccaro L
Adv Exp Med Biol (ISSN: 0065-2598, 0065-2598print), 2009; 611: 439-440.
Impact Factor: 2.02
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Elevated Expression of the Tyrosine Phosphatase SHP-1 Defines a Subset of High-Grade Breast Tumors (104 visite)
Insabato L, Amelio I, Quarto M, Zannetti A, Tolino F, De Mauro G, Cerchia L, Riccio P, Baumhoer D, Condorelli G, Terracciano L, De Franciscis V
Oncology (ISSN: 0030-2414), 2009; 77(6): 378-384.
Impact Factor: 2.112
Dettagli    Esporta in BibTeX    Esporta in EndNote

* An Improved Radiolabeling Synthesis of RGDECHI with 18F-Fluoride (115 visite)
Panico M, Lang L, Del Vecchio S, Nardelli A, Castaldi E, Zaccaro L, Del Gatto A, Saviano M, Zannetti A, Larobina M, Gargiulo S, Pedone C, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging of lung cancer resistance to EGFR tyrosine kinase inhibitors through Bcl-2/Bcl-x(L) modulation of inositol trisphosphate receptor type (102 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type (168 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Pirozzi G, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2008 Aug 15; 14(16): 5209-5219.
Impact Factor: 6.488
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Imaging Of Lung Cancer Resistance To Egfr Tyrosine Kinase Inhibitors Trough Bcl-2/Bcl-Xl Modulation Of Inositol Trisphosphate Receptor Type (101 visite)
Zannetti A, Iommelli F, Fonti R, Papaccioli A, Sommella J, Lettieri A, Bianco R, Tortora G, Salvatore M, Del Vecchio S
Eur J Nucl Med, 2008; suppl2: N/D-N/D.
Impact Factor: 5.563
Dettagli    Esporta in BibTeX    Esporta in EndNote

* In vivo imaging of alpha(v) beta(3) integrin expression with a radiolabeled chimeric RGD peptide (107 visite)
Del Vecchio S, Zannetti A, Panico M, Speranza A, Iommelli F, Papaccioli A, Sommella J, Lettieri A, Saviano M, Zaccaro L, Del Gatto A, Lang L, Pedone C, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: N/D-N/D.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

* SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer (129 visite)
Zannetti A, Fonti R, Iommelli F, Papaccioli A, Sommella J, Tortora G, Bianco R, Salvatore M, Del Vecchio S
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2007 Oct; 34: 277-309.
Impact Factor: 4.101
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Nuclear imaging in cancer theranostics (194 visite)
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
Q J Nucl Med Mol Imaging (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli    Esporta in BibTeX    Esporta in EndNote

* A new and selective radiolabeled alpha(v)beta 3 peptide antagonist as tracer in tumor diagnosis (90 visite)
Zaccaro L, Del Gatto A,  De Luca S, Ruvo M, Zannetti A, Del Vecchio S, Salvatore M, Pedone C, Saviano M
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2007; 88(4): N/D-N/D.
Impact Factor: 2.389
Dettagli    Esporta in BibTeX    Esporta in EndNote

* In vivo detection of early tumor response to tyrosine kinase inhibitors by microSPECT with 99mTc-MIBI (100 visite)
Del Vecchio S, Zannetti A, Iommelli F, Papaccioli A, Sommella J, Ferraro P, Baiano A, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Novel And Selective Alpha (v) Beta3 Receptor Peptide Antagonist: Design, Synthesis, And Biological Behavior (173 visite)
Del Gatto A, Zaccaro L, Grieco P, Novellino E, Zannetti A, Del Vecchio S, Iommelli F, Salvatore M, Pedone C, Saviano M
J Med Chem (ISSN: 0022-2623, 1520-4804, 0022-2623print), 2006 Jun 1; 49(11): 3416-3420.
Impact Factor: 5.115
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of NF-kappa B activity potentiates ionizing radiation and cisplatin induced cell killing of anaplastic thyroid carcinoma cells (119 visite)
Iommelli F, Zannetti A, Pepe S, Sabbatino F, Laus G, Ghidelli L, Solla R, Scala S, Del Vecchio S, Salvatore M, Pacelli R
Meetingproceedings Of The American Association For Cancer Research Annual (ISSN: 0197-016x), 2006 Apr; 47: N/D-N/D.
Impact Factor: 0
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Functional imaging of multidrug resistance in breast cancer (105 visite)
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Salvatore M
Phys Med (ISSN: 1120-1797, 1120-1797linking), 2006; 21(SUPPL.1): 24-27.
Impact Factor: 0.313
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Novel and selective alpha v beta 3 receptor peptide antagonist: Design, synthesis and biological behaviour (109 visite)
Del Gatto A, Zaccaro L, Zannetti A, Del Vecchio S, Benedetti E, Salvatore M, Pedone C, Saviano M
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2006; 12: N/D-N/D.
Impact Factor: 1.801
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells (138 visite)
Zannetti A, Del Vecchio S, Romanelli A, Scala S, Saviano M, Cali' G, Stoppelli MP, Pedone C, Salvatore M
Biochem Pharmacol Biochemical Pharmacology (ISSN: 0006-2952, 1873-2968), 2005 Nov 1; 70(9): 1277-1287.
Impact Factor: 3.617
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in Bcl-2 overexpressing breast cancer cells during treatment with gefitinib, a selective tyrosine kinase inhibitor (94 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Sommella I, Potena A, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Characterization of a novel RGD-containing peptide with improved selectivity for imaging alpha v beta 3 integrin expression (118 visite)
Del Vecchio S, Zannetti A, Del Gatto A, Grieco P, Iommelli F, Zaccaro L, Panico M, Saviano M, Blystone SD, Pedone C, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2005 Sep; 32: N/D-N/D.
Impact Factor: 3.883
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Gefitinib, A Selective, Tyrosine Kinase Inhibitor Increases 99mtc-Mibi Uptake In Bcl-2 Overexpressing Breast Cancer Cells (86 visite)
Zannetti A, Del Vecchio S, Fonti R, Iommelli F, Sommella J, Potena A, Salvatore M
Mol Immunol, 2005; 4: 355-355.
Impact Factor: 3.003
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis (97 visite)
Del Vecchio S, Zannetti A, Salvatore B, Paone G, Fonti R, Iommelli F, De Renzo A, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004 Sep; 31: N/D-N/D.
Impact Factor: 3.935
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Tc-99m-MIBI in the evaluation of breast cancer biology (232 visite)
Del Vecchio S, Zannetti A, Fonti R, Iommelli F, Salvatore M
Breast Cancer (ISSN: 9783-540367802), 2004 Jun; 1: 71-81.
Impact Factor: 0.635
Dettagli    Esporta in BibTeX    Esporta in EndNote

* In vitro and in vivo evaluation of In-111-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging (169 visite)
Aloj L, Caracò C, Panico M, Zannetti A, Del Vecchio S, Tesauro D, De Luca S, Arra C, Pedone C, Morelli G, Salvatore M
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2004 Mar; 45(3): 485-494.
Impact Factor: 5.362
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Bcl-2 overexpression prevents 99mTc-MIBI uptake in breast cancer cell lines (122 visite)
Aloj L, Zannetti A, Caracó C, Del Vecchio S, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2004; 31(4): 521-527.
Impact Factor: 3.935
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Functional Imaging Of Multidrug Resistant Phenotype By 99mtc-Mibi Scan In Patients With Multiple Myeloma (111 visite)
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Catalano L, Pace L, Rotoli B, Salvatore M
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004; 19(2): 165-170.
Impact Factor: 1.091
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Inhibition of early Tc-99m-MIBI uptake by Bcl-2 anti-apoptotic protein overexpression in untreated breast carcinoma (143 visite)
Del Vecchio S, Zannetti A, Aloj L, Caracò C, Ciarmiello A, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2003 Jun; 30(6): 879-887.
Impact Factor: 3.324
Dettagli    Esporta in BibTeX    Esporta in EndNote

* MIBI as prognostic factor in breast cancer (96 visite)
Del Vecchio S, Zannetti A, Aloj L, Salvatore M
Q J Nucl Med (ISSN: 1124-3937, 1125-0135), 2003 Mar; 47(1): 46-50.
Impact Factor: 2.222
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Dynamic coupling of Tc-99m-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients (128 visite)
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Caracò C, Fonti R, Botti G, D'Aiuto G, Salvatore M
Eur J Nucl Med (ISSN: 1619-7070, 0340-6997, 1619-7089), 2002 Jun; 29(6): 809-814.
Impact Factor: 3.568
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Radiolabeling approaches for cholecystokinin B receptor imaging (147 visite)
Aloj L, Panico M, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2002; 66(6): 370-380.
Impact Factor: 2.372
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake and Bcl-2 overexpression in untreated breast cancer patients (91 visite)
Del Vecchio S, Zannetti A, Ciarmiello A, Aloj L, Fonti R, Caraco C, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine (95 visite)
Aloj L, Zannetti A, Caraco C, Fonti R, Del Vecchio S, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* 99mTc-MIBI uptake is reduced in Bcl-2 overexpressing MCF-7 breast cancer cells (88 visite)
Aloj L, Del Vecchio S, Zannetti A, Caracò C, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Characterization of 111In labeled CCK8 peptide coupled to a novel DTPA-like derivative in CCK-B receptor overexpressing cells (102 visite)
Aloj L, Zannetti A, Caraco C, Del Vecchio S, Tasauro D,  De Luca S, Brunetti A, Aime S, Morelli G, Pedone C
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001 Sep; 28(8): N/D-N/D.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

* Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma (98 visite)
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 2001; 28(2): 214-220.
Impact Factor: 3.464
Dettagli    Esporta in BibTeX    Esporta in EndNote

Efflux rate of Tc-99m-MIBI and apoptosis in untreated breast cancer patients (103 visite)
Del Vecchio S, Ciarmiello A, Zannetti A, Fonti R, Botti G, D'Aiuto G, Salvatore M
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 2000 May; 41(5): N/D-N/D.
Impact Factor: 3.617
Dettagli    Esporta in BibTeX    Esporta in EndNote

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma (116 visite)
Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, Salvatore M
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 2000 Mar 15; 60(6): 1546-1551.
Impact Factor: 8.46
Dettagli    Esporta in BibTeX    Esporta in EndNote

Urokinase receptor interacts with alpha(v)beta(5) vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer (122 visite)
Carriero M, Del Vecchio S, Capozzoli M, Franco P, Fontana L, Zannetti A, Botti G, D'Aiuto G, Salvatore M, Stoppelli M
Cancer Res (ISSN: 0008-5472, 1538-7445, 1538-7445electronic), 1999 Oct 15; 59(20): N/D-N/D.
Impact Factor: 8.614
Dettagli    Esporta in BibTeX    Esporta in EndNote

Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma (87 visite)
Fonti R, Del Vecchio S, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
Dettagli    Esporta in BibTeX    Esporta in EndNote

Fractional retention of 99mTc-MIBI and proliferation in untreated breast cancer (94 visite)
Aloj L, Del Vecchio S, Damiano M, Zannetti A, Di Gennaro F, Imbriaco M, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
Dettagli    Esporta in BibTeX    Esporta in EndNote

Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma (101 visite)
Del Vecchio S, Fonti R, Zannetti A, De Renzo A, Di Gennaro F, Catalano L, Califano C, Pace L, Rotoli B, Salvatore M
Eur J Nucl Med (ISSN: 0340-6997, 1619-7070, 1619-7089), 1999 Sep; 26(9): N/D-N/D.
Impact Factor: 3.239
Dettagli    Esporta in BibTeX    Esporta in EndNote



73 Records (45 escludendo Abstract e Conferenze).
Impact factor totale: 298.166 (186.678 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 309.879 (187.13 escludendo Abstract e Conferenze).








Ultima modifica di Antonella Zannetti in data Wednesday 13 January 2016, 14:24:53
2702 visite. Ultima visita in data Tuesday 19 February 2019, 17:44:49

Webmaster and developer: Marco Comerci
Per problemi e suggerimenti: adminibb.cnr.it
Ultimo aggiornamento: Wednesday 20 February 2019, 11:48:26